CD47 and osteosarcoma: However, in osteosarcoma cells, HIF-1α and HIF-2α expression levels were not obviously increased upon doxorubicin treatment (Supplementary Fig. 18a), suggesting that HIF-mediated signaling is not evident in inducing CD47 upregulation in osteosarcoma and mechanisms that regulate CD47 expression can be tumor type-dependent.